Overall verdict
Neutral
4.7/10
1-year performance
+26.71%
Score breakdown
Up 26.7% over 1 year, 92% of the 52-week range.
Strongest: Shareholder return 6.1/10. Weakest: Growth 2.5/10.
18 analysts, target +0.1% vs the price.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK ; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors.
It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging.
Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Sector
Industrials
Industry
Industrial Conglomerates
Primary listing
Nyse
United States
CEO
Lori Koch
Founded
2015
Employees
15 000
Revenue / employee
456 600 USD
Next earnings
February 9, 2027 (estimated)
Institutional holders
- GEODE CAPITAL MANAGEMENT, LLC2.83%
- Bank of New York Mellon Corp0.81%
- FMR LLC0.71%
- Rest of the register95.65%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
157.98 USD
52-week low
111.15 USD
1-year performance
26.71%
Rising
Year-to-date performance
27.02%
Rising
Drawdown
-2.46%
Near its high
Position in the 52-week range
92% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did clearly worse than the world ETF once risk is accounted for. It earned less, while shaking 2.6 times harder.
$10,000 placed at the end of December 2000 are worth today
| DuPont de Nemours | $4,249 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves 2.6 times as much as the world ETF.
- Worst fall:-88Â % between January 2018 and March 2020. $10,000 placed at the top fell to $1,232. The world ETF, at worst: -53Â %. The share has not returned to its high yet.
DuPont de Nemours earned less than the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- DuPont de Nemours: $4,249
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Share price without dividends; the world ETF and the index reinvest theirs. A dividend payer is therefore understated here.
Based on past performance. This is not a recommendation.
Range: 60.13 USD - 79.62 USD (2 methods agree)
The price implies growth of 8.12% per year; the company grows at -10.00%.
Gross margin 31.6%, net margin 5.5%, ROIC 1.7%, ROE 2.1%.
Net margin
5.49%
Fair
Sector 7.68%|S&P 13.40%
Gross margin
31.60%
High
Return on equity (ROE)
2.13%
Low
Sector 9.01%|S&P 17.06%
Return on invested capital (ROIC)
1.65%
Low
Free cash flow margin (FCF)
11.39%
Exceptional
Profit-to-cash conversion (FCF conversion)
2.07x
Exceptional
Margin stability
20.2 pts
Very uneven
Revenue to net income
Growth
2.5/10Revenue up 4.1% over 1 year, -13.7% a year over 5.
Revenue (trailing 12 months)
7.1Md USD
Revenue growth (1y)
4.07%
Moderate
Revenue growth (3y)
-47.38%
Declining
EPS growth (1y)
—
EPS CAGR (5y)
—
EPS revisions (3 months)
3.78%
Revised up
Valuation
2.9/10P/E 69.7x, forward P/E 29.9x, EV/EBITDA 13.3x.
P/E (TTM)
69.7x
Very expensive
Sector 12.3x|S&P 23.6x
Forward P/E
29.9x
Expensive
EV / EBITDA
13.3x
Expensive
Sector 9.9x|S&P 15.5x
PEG
—
Sector 0.90|S&P 0.91
Fair value (reverse DCF)
68.32 USD
Deeply overvalued
Market cap
20.4Md USD
Financial strength
5.9/10Cash covers 53.6% of the debt, net debt/EBITDA 1.8x.
Net debt / EBITDA
1.8x
Very solid
Gearing (net debt / equity)
10.48%
Stretched
Cash
1.7Md USD
Cash / market cap
8.12%
Solid
Cash / total debt
53.62%
Solid
Interest coverage
5.6x
Solid
Net debt
1.4Md USD
Equity
13.7Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 156.88 USD
- MM20140.04
- MM50134.01
- MM200139.12
- RSI 1473.0
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.89%
200-day average slope, 3 months
+0.24%
50-day average slope, 1 month
-0.41%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
2.57 % per day
Volatility change
+53.05%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 5.16 (3) | 7.52 (14) | 7 194 (12) | 1 786 (12) | 699 (3) |
| 2027 | 6.16 (3) | 8.17 (18) | 7 500 (15) | 1 901 (15) | 814 (3) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 6, 2026.
Same sub-industry: 118 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A402340 | 7.1 | 7.3 | 74.3Md USD | 3.5x | 2665.9 % | -7.6 % | 85.5 % | — | — | 148.9 % | ||
| 2 | 6501 | 6.8 | 6.4 | 138Md USD | 30.0x | 6.5 % | 14.8 % | 10.6 % | -0.2x | 6.0 % | -3.0 % | ||
| 3 | SIE | 6.3 | 6.1 | 229Md USD | 27.4x | 9.7 % | 7.3 % | 7.3 % | 3.3x | 5.0 % | 11.5 % | ||
| 4 | 1 | 6.1 | 6.2 | 35.1Md USD | 7.0x | 13.6 % | -0.5 % | 4.5 % | 2.9x | 17.2 % | 29.2 % | ||
| 5 | 267 | 5.5 | 5.9 | 47.8Md USD | 5.5x | 7.6 % | 3.0 % | — | — | — | 0.4 % | ||
| 6 | MMM | 5.4 | 5.0 | 97.6Md USD | 28.2x | 14.0 % | 1.0 % | 20.8 % | 1.2x | 2.7 % | 12.6 % | ||
| 7 | IHC | 5.4 | 6.0 | 191Md USD | 21.0x | 23.9 % | 30.8 % | 12.7 % | -3.1x | 1.6 % | -20.8 % | ||
| 8 | HON | 5.1 | 4.6 | 72.2Md USD | 9.7x | 22.6 % | 1.3 % | 18.7 % | 2.6x | 2.1 % | 10.5 % | ||
| 9 | DD | 4.7 | 3.5 | 20.4Md USD | 69.7x | 5.5 % | 4.1 % | 1.7 % | 1.8x | 3.9 % | 26.7 % |
